Children who received the AstraZeneca or Pfizer-BioNTech COVID-19 vaccines faced an elevated risk of epilepsy and appendicitis, according to a new study.
Females in the age group also faced an increased risk of demyelinating disease after receiving a second dose of the vaccine.
A secondary analysis, involving matching some of the vaccine recipients to unvaccinated children, confirmed an increased risk among 12- to 17-year-olds of hospitalization with epilepsy following Pfizer vaccination, and elevated risks of severe allergic shock and appendicitis in the age group following Pfizer vaccination.
No increased risks of any outcome were identified among minor Moderna or AstraZeneca recipients.
Among a group of 18- to 24-year-olds studied, elevated risks of a number of conditions were found, including myocarditis, immune or idiopathic thrombocytopenia, epilepsy, and acute pancreatitis.
The authors cited in part how they found unvaccinated children faced increased risks of some of the outcomes, including multisystem inflammatory syndrome in children.
Udi Qimron, a professor at Tel Aviv University's Department of Clinical Microbiology and Immunology, said that the authors wrongly downplayed the risks associated with the vaccines.
No comments:
Post a Comment